Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Q: How big is the rabies vaccine market?

And in terms of application the largest application is Postexposure Prophylaxis followed by Preexposure Prophylaxis.Market Analysis and Insights Global Rabies Vaccine MarketIn 2020 the global Rabies Vaccine market size was US 877 million and it is expected to reach US 1178 million by the end of 2027 with a CAGR of 4.0 during 20212027.Global Rabies Vaccin.

Q: Who are the key players in the rabies vaccine market?

Some of the key players are GSK (Novartis), Sanofi Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT, Hissen, GSK, Russia, Others.

Code: QYRE-Auto-34M23

Report

September 2021

113 Pages

QYResearch

Region: Global, Africa, China, Europe, North America, Asia, Central & South America, Middle East, Asia Pacific,

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

GSK (Novartis)

Sanofi Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

GSK

Russia

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

Market Analysis and Insights: Global Rabies Vaccine Market

In 2020, the global Rabies Vaccine market size was US$ 877 million and it is expected to reach US$ 1178 million by the end of 2027, with a CAGR of 4.0% during 2021-2027.

Global Rabies Vaccine Scope and Market Size

Rabies Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Rabies Vaccine market is segmented into

Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others

Segment by Application, the Rabies Vaccine market is segmented into

Pre-exposure Prophylaxis
Post-exposure Prophylaxis

Regional and Country-level Analysis:

North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Rabies Vaccine Market Share Analysis

Rabies Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Rabies Vaccine product introduction, recent developments, Rabies Vaccine sales by region, type, application and by sales channel.

The major companies include:

GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen

FEATURED COMPANIES

GSK (Novartis)

Sanofi Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

GSK

Russia

1 Study Coverage

1.1 Rabies Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Rabies Vaccine Market Size Growth Rate by Type

1.2.2 Vero Cell Rabies Vaccine

1.2.3 BHK

1.2.4 Chick Embryo Cell Rabies Vaccine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Rabies Vaccine Market Size Growth Rate by Application

1.3.2 Pre-exposure Prophylaxis

1.3.3 Post-exposure Prophylaxis

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Rabies Vaccine Market Size Estimates and Forecasts

2.1.1 Global Rabies Vaccine Revenue 2016-2027

2.1.2 Global Rabies Vaccine Sales 2016-2027

2.2 Rabies Vaccine Market Size by Region: 2021 Versus 2027

2.3 Rabies Vaccine Sales by Region (2016-2027)

2.3.1 Global Rabies Vaccine Sales by Region: 2016-2021

2.3.2 Global Rabies Vaccine Sales Forecast by Region (2022-2027)

2.3.3 Global Rabies Vaccine Sales Market Share by Region (2016-2027)

2.4 Rabies Vaccine Market Estimates and Projections by Region (2022-2027)

2.4.1 Global Rabies Vaccine Revenue by Region: 2016-2021

2.4.2 Global Rabies Vaccine Revenue Forecast by Region (2022-2027)

2.4.3 Global Rabies Vaccine Revenue Market Share by Region (2016-2027)

3 Global Rabies Vaccine by Manufacturers

3.1 Global Top Rabies Vaccine Manufacturers by Sales

3.1.1 Global Rabies Vaccine Sales by Manufacturer (2016-2021)

3.1.2 Global Rabies Vaccine Sales Market Share by Manufacturer (2016-2021)

3.2 Global Top Rabies Vaccine Manufacturers by Revenue

3.2.1 Global Rabies Vaccine Revenue by Manufacturer (2016-2021)

3.2.2 Global Rabies Vaccine Revenue Share by Manufacturer (2016-2021)

3.3 Global Rabies Vaccine Price by Manufacturer (2016-2021)

3.4 Competitive Landscape

3.4.1 Key Rabies Vaccine Manufacturers Covered: Ranking by Revenue

3.4.2 Global Rabies Vaccine Market Concentration Ratio (CR5 and HHI) & (2016-2021)

3.4.3 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Rabies Vaccine Manufacturing Base Distribution, Product Type

3.5.1 Rabies Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Rabies Vaccine Product Type

3.5.3 Date of International Manufacturers Enter into Rabies Vaccine Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 GSK (Novartis)

4.1.1 GSK (Novartis) Corporation Information

4.1.2 GSK (Novartis) Description, Business Overview

4.1.3 GSK (Novartis) Rabies Vaccine Products Offered

4.1.4 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)

4.1.5 GSK (Novartis) Rabies Vaccine Revenue by Product

4.1.6 GSK (Novartis) Rabies Vaccine Revenue by Application

4.1.7 GSK (Novartis) Rabies Vaccine Revenue by Geographic Area

4.1.8 GSK (Novartis) Rabies Vaccine Revenue by Sales Channel

4.1.9 GSK (Novartis) Recent Development

4.2 Sanofi-Pasteur

4.2.1 Sanofi-Pasteur Corporation Information

4.2.2 Sanofi-Pasteur Description, Business Overview

4.2.3 Sanofi-Pasteur Rabies Vaccine Products Offered

4.2.4 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)

4.2.5 Sanofi-Pasteur Rabies Vaccine Revenue by Product

4.2.6 Sanofi-Pasteur Rabies Vaccine Revenue by Application

4.2.7 Sanofi-Pasteur Rabies Vaccine Revenue by Geographic Area

4.2.8 Sanofi-Pasteur Rabies Vaccine Revenue by Sales Channel

4.2.9 Sanofi-Pasteur Recent Development

4.3 Chengda

4.3.1 Chengda Corporation Information

4.3.2 Chengda Description, Business Overview

4.3.3 Chengda Rabies Vaccine Products Offered

4.3.4 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)

4.3.5 Chengda Rabies Vaccine Revenue by Product

4.3.6 Chengda Rabies Vaccine Revenue by Application

4.3.7 Chengda Rabies Vaccine Revenue by Geographic Area

4.3.8 Chengda Rabies Vaccine Revenue by Sales Channel

4.3.9 Chengda Recent Development

4.4 Yisheng

4.4.1 Yisheng Corporation Information

4.4.2 Yisheng Description, Business Overview

4.4.3 Yisheng Rabies Vaccine Products Offered

4.4.4 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)

4.4.5 Yisheng Rabies Vaccine Revenue by Product

4.4.6 Yisheng Rabies Vaccine Revenue by Application

4.4.7 Yisheng Rabies Vaccine Revenue by Geographic Area

4.4.8 Yisheng Rabies Vaccine Revenue by Sales Channel

4.4.9 Yisheng Recent Development

4.5 Prcmise

4.5.1 Prcmise Corporation Information

4.5.2 Prcmise Description, Business Overview

4.5.3 Prcmise Rabies Vaccine Products Offered

4.5.4 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)

4.5.5 Prcmise Rabies Vaccine Revenue by Product

4.5.6 Prcmise Rabies Vaccine Revenue by Application

4.5.7 Prcmise Rabies Vaccine Revenue by Geographic Area

4.5.8 Prcmise Rabies Vaccine Revenue by Sales Channel

4.5.9 Prcmise Recent Development

4.6 VACN

4.6.1 VACN Corporation Information

4.6.2 VACN Description, Business Overview

4.6.3 VACN Rabies Vaccine Products Offered

4.6.4 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)

4.6.5 VACN Rabies Vaccine Revenue by Product

4.6.6 VACN Rabies Vaccine Revenue by Application

4.6.7 VACN Rabies Vaccine Revenue by Geographic Area

4.6.8 VACN Recent Development

4.7 Changsheng

4.7.1 Changsheng Corporation Information

4.7.2 Changsheng Description, Business Overview

4.7.3 Changsheng Rabies Vaccine Products Offered

4.7.4 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)

4.7.5 Changsheng Rabies Vaccine Revenue by Product

4.7.6 Changsheng Rabies Vaccine Revenue by Application

4.7.7 Changsheng Rabies Vaccine Revenue by Geographic Area

4.7.8 Changsheng Recent Development

4.8 BCHT

4.8.1 BCHT Corporation Information

4.8.2 BCHT Description, Business Overview

4.8.3 BCHT Rabies Vaccine Products Offered

4.8.4 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)

4.8.5 BCHT Rabies Vaccine Revenue by Product

4.8.6 BCHT Rabies Vaccine Revenue by Application

4.8.7 BCHT Rabies Vaccine Revenue by Geographic Area

4.8.8 BCHT Recent Development

4.9 Hissen

4.9.1 Hissen Corporation Information

4.9.2 Hissen Description, Business Overview

4.9.3 Hissen Rabies Vaccine Products Offered

4.9.4 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2016-2021)

4.9.5 Hissen Rabies Vaccine Revenue by Product

4.9.6 Hissen Rabies Vaccine Revenue by Application

4.9.7 Hissen Rabies Vaccine Revenue by Geographic Area

4.9.8 Hissen Recent Development

5 Breakdown Data by Type

5.1 Global Rabies Vaccine Sales by Type (2016-2027)

5.1.1 Global Rabies Vaccine Sales by Type (2016-2021)

5.1.2 Global Rabies Vaccine Sales Forecast by Type (2022-2027)

5.1.3 Global Rabies Vaccine Sales Market Share by Type (2016-2027)

5.2 Global Rabies Vaccine Revenue Forecast by Type (2016-2027)

5.2.1 Global Rabies Vaccine Revenue by Type (2016-2021)

5.2.2 Global Rabies Vaccine Revenue Forecast by Type (2022-2027)

5.2.3 Global Rabies Vaccine Revenue Market Share by Type (2016-2027)

5.3 Rabies Vaccine Average Selling Price (ASP) by Type (2016-2027)

6 Breakdown Data by Application

6.1 Global Rabies Vaccine Sales by Application (2016-2027)

6.1.1 Global Rabies Vaccine Sales by Application (2016-2021)

6.1.2 Global Rabies Vaccine Sales Forecast by Application (2022-2027)

6.1.3 Global Rabies Vaccine Sales Market Share by Application (2016-2027)

6.2 Global Rabies Vaccine Revenue Forecast by Application (2016-2027)

6.2.1 Global Rabies Vaccine Revenue by Application (2016-2021)

6.2.2 Global Rabies Vaccine Revenue Forecast by Application (2022-2027)

6.2.3 Global Rabies Vaccine Revenue Market Share by Application (2016-2027)

6.3 Rabies Vaccine Average Selling Price (ASP) by Application (2016-2027)

7 North America

7.1 North America Rabies Vaccine Market Size YoY Growth 2016-2027

7.2 North America Rabies Vaccine Market Facts & Figures by Country

7.2.1 North America Rabies Vaccine Sales by Country (2016-2027)

7.2.2 North America Rabies Vaccine Revenue by Country (2016-2027)

7.3 North America Rabies Vaccine Sales by Type

7.4 North America Rabies Vaccine Sales by Application

8 Asia-Pacific

8.1 Asia-Pacific Rabies Vaccine Market Size YoY Growth 2016-2027

8.2 Asia-Pacific Rabies Vaccine Market Facts & Figures by Region

8.2.1 Asia-Pacific Rabies Vaccine Sales by Region (2016-2027)

8.2.2 Asia-Pacific Rabies Vaccine Revenue by Region (2016-2027)

8.3 Asia-Pacific Rabies Vaccine Sales by Type

8.4 Asia-Pacific Rabies Vaccine Sales by Application

9 Europe

9.1 Europe Rabies Vaccine Market Size YoY Growth 2016-2027

9.2 Europe Rabies Vaccine Market Facts & Figures by Country

9.2.1 Europe Rabies Vaccine Sales by Country (2016-2027)

9.2.2 Europe Rabies Vaccine Revenue by Country (2016-2027)

9.3 Europe Rabies Vaccine Sales by Type

9.4 Europe Rabies Vaccine Sales by Application

10 Latin America

10.1 Latin America Rabies Vaccine Market Size YoY Growth 2016-2027

10.2 Latin America Rabies Vaccine Market Facts & Figures by Country

10.2.1 Latin America Rabies Vaccine Sales by Country (2016-2027)

10.2.2 Latin America Rabies Vaccine Revenue by Country (2016-2027)

10.3 Latin America Rabies Vaccine Sales by Type

10.4 Latin America Rabies Vaccine Sales by Application

11 Middle East and Africa

11.1 Middle East and Africa Rabies Vaccine Market Size YoY Growth 2016-2027

11.2 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country

11.2.1 Middle East and Africa Rabies Vaccine Sales by Country (2016-2027)

11.2.2 Middle East and Africa Rabies Vaccine Revenue by Country (2016-2027)

11.3 Middle East and Africa Rabies Vaccine Sales by Type

11.4 Middle East and Africa Rabies Vaccine Sales by Application

12 Supply Chain and Sales Channel Analysis

12.1 Rabies Vaccine Supply Chain Analysis

12.2 Rabies Vaccine Key Raw Materials and Upstream Suppliers

12.3 Rabies Vaccine Clients Analysis

12.4 Rabies Vaccine Sales Channel and Sales Model Analysis

12.4.1 Rabies Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Rabies Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Rabies Vaccine Distributors

13 Market Dynamics

13.1 Rabies Vaccine Market Drivers

13.2 Rabies Vaccine Market Opportunities

13.3 Rabies Vaccine Market Challenges

13.4 Rabies Vaccine Market Restraints

13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

GSK (Novartis)

Sanofi Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

GSK

Russia

List of Tables

Table 1. Global Rabies Vaccine Market Size Growth Rate by Type (US$ Million): 2021 VS 2027

Table 2. Major Manufacturers of Vero Cell Rabies Vaccine

Table 3. Major Manufacturers of BHK

Table 4. Major Manufacturers of Chick Embryo Cell Rabies Vaccine

Table 5. Major Manufacturers of Others

Table 6. Global Rabies Vaccine Market Size Growth by Application (US$ Million): 2021 VS 2027

Table 7. Global Rabies Vaccine Market Size by Region (US$ Million): 2021 VS 2027

Table 8. Global Rabies Vaccine Sales by Region (2016-2021) & (K Units)

Table 9. Global Rabies Vaccine Sales Forecast by Region (2022-2027) & (K Units)

Table 10. Global Rabies Vaccine Revenue by Region (2016-2021) & (US$ Million)

Table 11. Global Rabies Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 12. Global Rabies Vaccine Sales by Manufacturer (2016-2021) & (K Units)

Table 13. Global Rabies Vaccine Sales Share by Manufacturer (2016-2021)

Table 14. Rabies Vaccine Revenue by Manufacturer (2016-2021) & (US$ Million)

Table 15. Rabies Vaccine Revenue Share by Manufacturer (2016-2021)

Table 16. Key Manufacturers Rabies Vaccine Price (2016-2021) & (USD/Unit)

Table 17. Ranking of Global Top Rabies Vaccine Manufacturers by Revenue (US$ Million) in 2020

Table 18. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)

Table 19. Global Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2020)

Table 20. Rabies Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

Table 21. Manufacturers Rabies Vaccine Product Type

Table 22. Date of International Manufacturers Enter into Rabies Vaccine Market

Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 24. GSK (Novartis) Corporation Information

Table 25. GSK (Novartis) Description and Business Overview

Table 26. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

Table 27. GSK (Novartis) Rabies Vaccine Product

Table 28. GSK (Novartis) Rabies Vaccine Revenue (US$ Million) and Market Share by Product

Table 29. GSK (Novartis) Rabies Vaccine Revenue (US$ Million) and Market Share by Application

Table 30. GSK (Novartis) Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 31. GSK (Novartis) Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 32. GSK (Novartis) Recent Development

Table 33. Sanofi-Pasteur Corporation Information

Table 34. Sanofi-Pasteur Description and Business Overview

Table 35. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

Table 36. Sanofi-Pasteur Rabies Vaccine Product

Table 37. Sanofi-Pasteur Rabies Vaccine Revenue (US$ Million) and Market Share by Product

Table 38. Sanofi-Pasteur Rabies Vaccine Revenue (US$ Million) and Market Share by Application

Table 39. Sanofi-Pasteur Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 40. Sanofi-Pasteur Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 41. Sanofi-Pasteur Recent Development

Table 42. Chengda Corporation Information

Table 43. Chengda Description and Business Overview

Table 44. Chengda Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

Table 45. Chengda Rabies Vaccine Product

Table 46. Chengda Rabies Vaccine Revenue (US$ Million) and Market Share by Product

Table 47. Chengda Rabies Vaccine Revenue (US$ Million) and Market Share by Application

Table 48. Chengda Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 49. Chengda Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 50. Chengda Recent Development

Table 51. Yisheng Corporation Information

Table 52. Yisheng Description and Business Overview

Table 53. Yisheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

Table 54. Yisheng Rabies Vaccine Product

Table 55. Yisheng Rabies Vaccine Revenue (US$ Million) and Market Share by Product

Table 56. Yisheng Rabies Vaccine Revenue (US$ Million) and Market Share by Application

Table 57. Yisheng Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 58. Yisheng Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 59. Yisheng Recent Development

Table 60. Prcmise Corporation Information

Table 61. Prcmise Description and Business Overview

Table 62. Prcmise Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

Table 63. Prcmise Rabies Vaccine Product

Table 64. Prcmise Rabies Vaccine Revenue (US$ Million) and Market Share by Product

Table 65. Prcmise Rabies Vaccine Revenue (US$ Million) and Market Share by Application

Table 66. Prcmise Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 67. Prcmise Rabies Vaccine Revenue (US$ Million) and Market Share by Sales Channel

Table 68. Prcmise Recent Development

Table 69. VACN Corporation Information

Table 70. VACN Description and Business Overview

Table 71. VACN Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

Table 72. VACN Rabies Vaccine Product

Table 73. VACN Rabies Vaccine Revenue (US$ Million) and Market Share by Product

Table 74. VACN Rabies Vaccine Revenue (US$ Million) and Market Share by Application

Table 75. VACN Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 76. VACN Recent Development

Table 77. Changsheng Corporation Information

Table 78. Changsheng Description and Business Overview

Table 79. Changsheng Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

Table 80. Changsheng Rabies Vaccine Product

Table 81. Changsheng Rabies Vaccine Revenue (US$ Million) and Market Share by Product

Table 82. Changsheng Rabies Vaccine Revenue (US$ Million) and Market Share by Application

Table 83. Changsheng Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 84. Changsheng Recent Development

Table 85. BCHT Corporation Information

Table 86. BCHT Description and Business Overview

Table 87. BCHT Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

Table 88. BCHT Rabies Vaccine Product

Table 89. BCHT Rabies Vaccine Revenue (US$ Million) and Market Share by Product

Table 90. BCHT Rabies Vaccine Revenue (US$ Million) and Market Share by Application

Table 91. BCHT Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 92. BCHT Recent Development

Table 93. Hissen Corporation Information

Table 94. Hissen Description and Business Overview

Table 95. Hissen Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

Table 96. Hissen Rabies Vaccine Product

Table 97. Hissen Rabies Vaccine Revenue (US$ Million) and Market Share by Product

Table 98. Hissen Rabies Vaccine Revenue (US$ Million) and Market Share by Application

Table 99. Hissen Rabies Vaccine Revenue (US$ Million) and Market Share by Geographic Area

Table 100. Hissen Recent Development

Table 101. Global Rabies Vaccine Sales by Type (2016-2021) & (K Units)

Table 102. Global Rabies Vaccine Sales Forecast by Type (2022-2027) & (K Units)

Table 103. Global Rabies Vaccine Revenue by Type (2016-2021) & (US$ Million)

Table 104. Global Rabies Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)

Table 105. Global Rabies Vaccine Sales by Application (2016-2021) & (K Units)

Table 106. Global Rabies Vaccine Sales Forecast by Application (2022-2027) & (K Units)

Table 107. Global Rabies Vaccine Revenue by Application (2016-2021) & (US$ Million)

Table 108. Global Rabies Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)

Table 109. North America Rabies Vaccine Sales by Country (2016-2021) & (K Units)

Table 110. North America Rabies Vaccine Sales by Country (2022-2027) & (K Units)

Table 111. North America Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)

Table 112. North America Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)

Table 113. North America Rabies Vaccine Sales by Type (2016-2021) & (K Units)

Table 114. North America Rabies Vaccine Sales by Application (2016-2021) & (K Units)

Table 115. Asia-Pacific Rabies Vaccine Sales by Region (2016-2021) & (K Units)

Table 116. Asia-Pacific Rabies Vaccine Sales by Region (2022-2027) & (K Units)

Table 117. Asia-Pacific Rabies Vaccine Revenue by Region (2016-2027) & (US$ Million)

Table 118. Asia-Pacific Rabies Vaccine Revenue by Region (2022-2027) & (US$ Million)

Table 119. Asia-Pacific Rabies Vaccine Sales by Type (2016-2021) & (K Units)

Table 120. Asia-Pacific Rabies Vaccine Sales by Application (2016-2021) & (K Units)

Table 121. Europe Rabies Vaccine Sales by Country (2016-2021) & (K Units)

Table 122. Europe Rabies Vaccine Sales by Country (2022-2027) & (K Units)

Table 123. Europe Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)

Table 124. Europe Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)

Table 125. Europe Rabies Vaccine Sales by Type (2016-2021) & (K Units)

Table 126. Europe Rabies Vaccine Sales by Application (2016-2021) & (K Units)

Table 127. Latin America Rabies Vaccine Sales by Country (2016-2021) & (K Units)

Table 128. Latin America Rabies Vaccine Sales by Country (2022-2027) & (K Units)

Table 129. Latin America Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)

Table 130. Latin America Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)

Table 131. Latin America Rabies Vaccine Sales by Type (2016-2021) & (K Units)

Table 132. Latin America Rabies Vaccine Sales by Application (2016-2021) & (K Units)

Table 133. Middle East and Africa Rabies Vaccine Sales by Country (2016-2021) & (K Units)

Table 134. Middle East and Africa Rabies Vaccine Sales by Country (2022-2027) & (K Units)

Table 135. Middle East and Africa Rabies Vaccine Revenue by Country (2016-2021) & (US$ Million)

Table 136. Middle East and Africa Rabies Vaccine Revenue by Country (2022-2027) & (US$ Million)

Table 137. Middle East and Africa Rabies Vaccine Sales by Type (2016-2021) & (K Units)

Table 138. Middle East and Africa Rabies Vaccine Sales by Application (2016-2021) & (K Units)

Table 139. Rabies Vaccine Key Raw Materials, Industry Status and Trend

Table 140. Rabies Vaccine Key Raw Materials and Upstream Suppliers

Table 141. Rabies Vaccine Clients Status and Trend

Table 142. Rabies Vaccine Typical Clients

Table 143. Rabies Vaccine Distributors

Table 144. Key Drivers: Impact Analysis (2022-2027)

Table 145. Rabies Vaccine Market Drivers

Table 146. Rabies Vaccine Market Opportunities

Table 147. Rabies Vaccine Market Challenges

Table 148. Rabies Vaccine Market Restraints

Table 149. Rabies Vaccine Porter’s Five Forces Analysis

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

List of Figures

Figure 1. Rabies Vaccine Product Picture

Figure 2. Global Rabies Vaccine Sales Market Share by Type in 2021 & 2027

Figure 3. Vero Cell Rabies Vaccine Product Picture

Figure 4. BHK Product Picture

Figure 5. Chick Embryo Cell Rabies Vaccine Product Picture

Figure 6. Others Product Picture

Figure 7. Global Rabies Vaccine Sales Market Share by Application in 2021 & 2027

Figure 8. Pre-exposure Prophylaxis Examples

Figure 9. Post-exposure Prophylaxis Examples

Figure 10. Rabies Vaccine Report Years Considered

Figure 11. Global Rabies Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027

Figure 12. Global Rabies Vaccine Market Size 2016-2027 (US$ Million)

Figure 13. Global Rabies Vaccine Sales 2016-2027 (K Units)

Figure 14. Global Rabies Vaccine Market Size Market Share by Region: 2021 Versus 2027

Figure 15. Global Rabies Vaccine Sales Market Share Forecast by Region (2016-2027)

Figure 16. Global Rabies Vaccine Revenue Market Share by Region (2016-2027)

Figure 17. Global Rabies Vaccine Sales Share by Manufacturer in 2020

Figure 18. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

Figure 19. Global Rabies Vaccine Sales Market Share Forecast by Type (2016-2027)

Figure 20. Global Rabies Vaccine Revenue Market Share Forecast by Type (2016-2027)

Figure 21. Rabies Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)

Figure 22. Global Rabies Vaccine Sales Market Share Forecast by Application (2016-2027)

Figure 23. Global Rabies Vaccine Revenue Market Share Forecast by Application (2016-2027)

Figure 24. Rabies Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)

Figure 25. North America Rabies Vaccine Revenue 2016-2027 (US$ Million)

Figure 26. North America Rabies Vaccine Sales Market Share by Type (2016-2021)

Figure 27. North America Rabies Vaccine Sales Market Share by Application (2016-2021)

Figure 28. Asia-Pacific Rabies Vaccine Revenue 2016-2027 (US$ Million)

Figure 29. Asia-Pacific Rabies Vaccine Sales Market Share by Region (2016-2027)

Figure 30. Asia-Pacific Rabies Vaccine Revenue Market Share by Region (2016-2027)

Figure 31. Asia-Pacific Rabies Vaccine Sales Market Share by Type (2016-2021)

Figure 32. Asia-Pacific Rabies Vaccine Sales Market Share by Application (2016-2021)

Figure 33. Europe Rabies Vaccine Revenue Growth Rate 2016-2027 (US$ Million)

Figure 34. Europe Rabies Vaccine Sales Market Share by Country (2016-2027)

Figure 35. Europe Rabies Vaccine Revenue Market Share by Country (2016-2027)

Figure 36. Europe Rabies Vaccine Sales Market Share by Type (2016-2021)

Figure 37. Europe Rabies Vaccine Sales Market Share by Application (2016-2021)

Figure 38. Latin America Rabies Vaccine Revenue Growth Rate 2016-2027 (US$ Million)

Figure 39. Latin America Rabies Vaccine Sales Market Share by Country (2016-2027)

Figure 40. Latin America Rabies Vaccine Revenue Market Share by Country (2016-2021)

Figure 41. Latin America Rabies Vaccine Sales Market Share by Type (2016-2021)

Figure 42. Latin America Rabies Vaccine Sales Market Share by Application (2016-2021)

Figure 43. Middle East and Africa Rabies Vaccine Revenue Growth Rate 2016-2027 (US$ Million)

Figure 44. Middle East and Africa Rabies Vaccine Sales Market Share by Country (2016-2027)

Figure 45. Middle East and Africa Rabies Vaccine Revenue Market Share by Country (2016-2027)

Figure 46. Middle East and Africa Rabies Vaccine Sales Market Share by Type (2016-2021)

Figure 47. Middle East and Africa Rabies Vaccine Sales Market Share by Application (2016-2021)

Figure 48. Rabies Vaccine Supply Chain (Upstream and Downstream Market)

Figure 49. Global Production Market Share of Rabies Vaccine Raw Materials by Region in 2020

Figure 50. Rabies Vaccine Distribution Channels

Figure 51. Global Rabies Vaccine Percentage 2016-2027: Indirect Sales VS Direct Sales

Figure 52. Global Rabies Vaccine Percentage 2016-2027: Online Sales VS Offline Sales

Figure 53. Porter's Five Forces Analysis

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

REPORTS VIEWED RECENTLY

Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Published Date: September 2021

Report Code: QYRE-Auto-34M23

Global Rabies Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Code: QYRE-Auto-34M23

Report

September 2021

113 Pages

QYResearch

Region: Global, Africa, China, Europe, North America, Asia, Central & South America, Middle East, Asia Pacific,

FEATURED COMPANIES

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

Segment by Type, the Rabies Vaccine market is segmented into

Segment by Application, the Rabies Vaccine market is segmented into

FEATURED COMPANIES

FEATURED COMPANIES

REPORTS VIEWED RECENTLY

SELECT A FORMAT

Single User

Electronic (PDF)

$5900

Multi User

Electronic (PDF)

$8850

Enterprise User

Electronic (PDF)

$11800

HAVE A QUERY?

OUR CUSTOMER

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-22Z1818

Sat Oct 02 00:00:00 UTC 2021

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-11H675

Mon Sep 27 00:00:00 UTC 2021

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-34M23

Mon Sep 27 00:00:00 UTC 2021

Add to Cart

120 Pages

Type: Report

Code: QYRE-Auto-28M6619

Tue Sep 21 00:00:00 UTC 2021

Add to Cart

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions